Digestive Health Lab Tests: Blood, Stool, Celiac, Inflammation, and Pancreatic Testing

Compare blood, stool, breath, celiac, inflammation, infection, malabsorption, and pancreatic tests—and learn when imaging, endoscopy, or biopsy may still be needed.

August 11, 2026

Share with a friend:

Digestive health lab tests use blood, stool, and sometimes breath samples to look for objective clues related to anemia, dehydration, inflammation, infection, celiac disease, nutrient malabsorption, pancreatic enzyme problems, hidden blood in stool, and selected conditions outside the digestive tract that can change bowel patterns. Common starting tests may include a Complete Blood Count with Differential and Platelets, a Comprehensive Metabolic Panel, focused inflammation markers, iron studies, and celiac serology. Targeted testing may include fecal calprotectin, active-infection H. pylori stool antigen or urea breath testing, stool pathogen testing, pancreatic elastase, and FIT for appropriate colorectal-cancer screening.

Digestive system connected to a blood tube, stool container, breath-sample bag, and laboratory report. — Digestive health testing may use blood, stool, or breath samples, while imaging or endoscopy may be needed for structural or tissue questions. No single test explains every digestive symptom.

Important Medical Safety Note

This guide is educational and does not diagnose a digestive disorder or replace medical care. Vomiting blood, black or tarry stool, substantial rectal bleeding, severe or rapidly worsening abdominal pain, persistent vomiting, fainting, jaundice, confusion, marked abdominal swelling, or signs of dehydration require prompt professional or emergency evaluation. Direct-access laboratory testing is not an emergency service and should not delay examination, imaging, endoscopy, intravenous fluids, or other urgent treatment.

Part of the Ulta Lab Tests Knowledge Center

This pillar explains how blood, stool, breath, and procedure-based testing fit together. Use these foundational guides for the broader testing process:

The Complete Guide to Lab Tests and Blood Work explains individual tests, panels, screening, diagnostic support, confirmation, and monitoring.
How to Read and Understand Your Lab Results explains reference intervals, flags, thresholds, units, biological variation, and trends.
Direct-Access Lab Testing: How It Works and What to Expect explains selection, ordering, preparation, collection, results, and responsible follow-up.

Digestive concerns frequently overlap with the Vitamin and Nutrient Deficiency Tests, CBC and Anemia Blood Tests, Inflammation and Autoimmune Blood Tests, Liver Function Tests, and Thyroid Blood Tests pillars. These cross-links help separate intestine-specific questions from systemic inflammation, anemia, nutrient, liver, and thyroid patterns that can produce overlapping symptoms.

Key Facts About Digestive Health Lab Tests

Test and quick facts	What it shows and how it is used	Preparation, influences, and limitations
CBC with differential and platelets First-line Specimen: blood	Looks for anemia, red-cell indices, white-cell changes, and platelet patterns. It may identify complications of blood loss, inflammation, infection, or malabsorption, but it does not locate the source.	Fasting is usually unnecessary when ordered alone. Hydration, pregnancy, altitude, recent illness, bleeding, medicines, and laboratory method can affect the pattern.
Comprehensive Metabolic Panel First-line Specimen: blood	Assesses selected electrolytes, kidney markers, glucose, calcium, proteins, bilirubin, and liver-associated enzymes. It may reveal dehydration, electrolyte disruption, low albumin, or hepatobiliary patterns.	Follow the instructions for the full order because accompanying tests may require fasting. A CMP cannot visualize bowel, gallbladder, bile ducts, liver tissue, or pancreas.
C-Reactive Protein and Sedimentation Rate Targeted Specimen: blood	Provides nonspecific evidence of systemic inflammation. These tests may add context when inflammatory bowel disease, infection, or another inflammatory process is possible.	Usually no fasting when ordered alone. Neither marker identifies the location or cause of inflammation, and normal results do not exclude localized intestinal disease.
tTG-IgA with Total IgA Targeted Specimen: blood	The usual starting serologic strategy for most people being evaluated for celiac disease. Total IgA determines whether an IgA-based result is likely to be interpretable.	Testing is most informative while eating gluten. IgA deficiency, reduced gluten exposure, mild disease, immunosuppression, and method can affect results. Endoscopy with biopsy may still be needed.
Calprotectin Stool Test TargetedMonitoring Specimen: stool	Provides an intestine-focused inflammatory signal. It may help distinguish an inflammatory process from a functional disorder and monitor selected patients with known inflammatory bowel disease.	Follow collection and storage instructions. Infection, NSAIDs, bleeding, age, and method can affect results. It does not identify Crohn’s disease, ulcerative colitis, infection, or another cause by itself.
H. pylori Stool Antigen or Urea Breath Test TargetedMonitoring Specimen: stool or breath	Looks for active H. pylori infection and can be used, at the correct time, to confirm eradication after treatment.	Acid-suppressing medicines, antibiotics, bismuth, food, recent treatment, and timing can affect accuracy. Follow the exact professional and laboratory instructions.
Gastrointestinal Pathogen Panel Targeted Specimen: stool	Detects selected bacterial, viral, or parasitic targets, depending on the product and method. It may be appropriate for severe, prolonged, bloody, febrile, travel-related, outbreak-associated, or immunocompromised diarrhea.	Correct stool type, prompt collection, transport, recent antibiotics, and clinical context matter. Molecular detection may reflect colonization or nonviable organisms and does not automatically establish the cause of symptoms.
Pancreatic Elastase-1 Targeted Specimen: solid or semisolid stool	Assesses pancreatic exocrine enzyme output when exocrine pancreatic insufficiency is suspected, especially with greasy stool, weight loss, or fat-soluble vitamin deficiency.	Watery stool can dilute the marker and produce a falsely low value. Performance is weaker in mild disease and low-pretest-probability settings. It does not show pancreatic anatomy.
FIT Test Risk-based screening Specimen: stool	Detects human hemoglobin as one guideline-supported colorectal-cancer screening option for eligible people without symptoms. A positive result requires colonoscopy.	Follow the kit. FIT generally does not require dietary restriction. It does not identify the bleeding source and is not a substitute for evaluating visible blood or black stool.
Lipase and Amylase Acute-care or targeted Specimen: blood	Supports evaluation of suspected acute pancreatic injury when symptoms are compatible. Lipase is generally more useful for suspected acute pancreatitis.	Severe acute pain or vomiting requires prompt clinical evaluation. These are not routine wellness tests and do not diagnose chronic pancreatitis or pancreatic exocrine insufficiency.
TSH with selected Free T4 Targeted Specimen: blood	Evaluates thyroid function when persistent constipation, frequent bowel movements, unexplained weight change, heat or cold intolerance, palpitations, thyroid history, or autoimmune clustering raises a thyroid question.	Not routine testing for every digestive complaint. Illness, pregnancy, medicines, supplements, timing, pituitary disease, and assay interference can affect interpretation. Thyroid testing does not replace digestive evaluation when warning signs are present.

What Is Digestive and Gastrointestinal Lab Testing?

The digestive system includes the gastrointestinal tract—the mouth, esophagus, stomach, small intestine, large intestine, rectum, and anus—along with the liver, pancreas, and gallbladder. These organs move food, break it down, absorb nutrients and water, produce or store digestive fluids, and eliminate waste.¹

Digestive health lab testing is not one universal panel. It is a group of blood, stool, breath, and tissue-based methods selected to answer different questions. Blood tests may reveal anemia, dehydration, electrolyte disturbance, systemic inflammation, liver-related patterns, pancreatic enzyme elevation, nutrient deficiency, thyroid dysfunction, or celiac-associated antibodies. Stool tests can look more directly for intestinal inflammation, hidden blood, pathogens, pancreatic enzyme output, or fat malabsorption. Breath tests may assess active H. pylori, lactose malabsorption, or selected carbohydrate-fermentation questions. Endoscopy and biopsy permit direct visualization and tissue sampling.

Symptoms alone often cannot identify the cause because bloating, diarrhea, constipation, abdominal pain, nausea, fatigue, and altered stool may occur with inflammatory, infectious, structural, metabolic, medication-related, dietary, or endocrine conditions, as well as disorders of gut-brain interaction. Objective testing can narrow the possibilities, but it may remain insufficient without a medical history, physical examination, imaging, endoscopy, biopsy, or other functional testing.

Why Digestive Health Lab Tests Matter

Digestive symptoms may be brief and self-limited, but persistent or recurrent symptoms can affect hydration, nutrient absorption, blood counts, body weight, bone health, energy, and quality of life. Testing can reveal complications even when it cannot establish the underlying diagnosis.

Short-term concerns: dehydration, electrolyte disturbance, acute infection, gastrointestinal bleeding, biliary obstruction, or pancreatic inflammation.
Long-term concerns: iron-deficiency anemia, vitamin deficiencies, protein loss, chronic intestinal inflammation, celiac disease, exocrine pancreatic insufficiency, and complications of established digestive disorders.
Baseline assessment: blood counts, electrolytes, proteins, liver markers, inflammation, and nutrient status before treatment or specialist evaluation.
Trend monitoring: known celiac disease, inflammatory bowel disease, documented nutrient deficiency, pancreatic insufficiency, or eradication of H. pylori.

A larger panel is not automatically more useful. A focused strategy begins with the question, dominant symptom pattern, duration, risk factors, medications, previous results, and the consequences of missing a serious condition or generating a false-positive result.

What Digestive Laboratory Testing May—and Cannot—Reveal

Clinical question	Tests that may add information	What the result can and cannot establish
Is there evidence of anemia or blood-cell disruption?	CBC, Ferritin, Iron and TIBC, Transferrin, and selected Reticulocyte Count.	May show an anemia pattern, depleted iron stores, white-cell change, or platelet response. It does not identify whether the cause is dietary, menstrual, gastrointestinal bleeding, inflammation, malabsorption, or another process.
Is dehydration or metabolic disruption present?	Comprehensive Metabolic Panel or selected electrolytes and kidney markers.	May identify fluid, electrolyte, kidney, glucose, protein, bilirubin, or liver-enzyme abnormalities. It cannot show the anatomic source of vomiting, diarrhea, obstruction, or biliary disease.
Is systemic or intestinal inflammation present?	CRP, ESR, Fecal Calprotectin, and Lactoferrin, Quantitative, Stool.	May provide a nonspecific systemic signal or a more intestine-focused inflammatory signal. It cannot diagnose Crohn’s disease, ulcerative colitis, infection, microscopic colitis, or another cause without the rest of the evaluation.
Is celiac disease a reasonable concern?	tTG-IgA, Total IgA, and selected EMA-IgA, DGP, tTG-IgG, or HLA testing.	May identify an antibody pattern that supports celiac evaluation. In many adults, gastroenterology review and upper endoscopy with duodenal biopsies remain important for confirmation.²³
Could infection be contributing?	GI Pathogen Panel, Ova and Parasites, targeted stool culture and toxin testing, C. difficile Toxin B, and active-infection H. pylori stool antigen or breath testing.	May detect a selected pathogen, toxin, antigen, viable organism, or microbial genetic material. Detection must be interpreted with symptoms, exposure, stool consistency, recent treatment, and the possibility of colonization.
Could pancreatic exocrine output or fat absorption be low?	Pancreatic Elastase-1, selected Fecal Fat, Vitamin D, Vitamin B12, and other focused nutrient tests.	May support pancreatic insufficiency or fat malabsorption. It does not identify the cause, pancreatic anatomy, bile-flow problem, or small-intestinal disease without follow-up.
Is occult colorectal bleeding detected during screening?	FIT or Fecal Globin by Immunochemistry in eligible, asymptomatic adults.	A positive screening result requires colonoscopy. A stool blood test cannot identify the source or diagnose colorectal cancer by itself, and it should not be used to evaluate visible bleeding.
Could a thyroid disorder be contributing to bowel-pattern changes?	TSH and selected Free T4, or the combined TSH and Free T4 Test.	May identify a thyroid-function pattern when constipation, frequent bowel movements, weight change, temperature intolerance, palpitations, thyroid history, or autoimmune risk is present. It does not explain every digestive symptom and is not a routine GI screen for everyone.²⁶

What Laboratory Testing Cannot Do by Itself

It Cannot See Anatomy

Blood and stool tests do not directly show ulcers, polyps, tumors, strictures, diverticula, gallstones, bowel obstruction, or the exact location of bleeding. Endoscopy, colonoscopy, ultrasound, CT, MRI, capsule endoscopy, or another procedure may be needed.

It Cannot Replace Tissue Diagnosis

CRP, ESR, calprotectin, celiac antibodies, ASCA, and ANCA cannot replace endoscopy and biopsy when tissue confirmation is required. A positive marker supports a pathway; it does not complete every diagnosis.

It Cannot Rule Out All Serious Disease

Some structural, microscopic, inflammatory, pancreatic, gallbladder, and malignant conditions may have normal routine blood work. Persistent warning symptoms require reassessment even when an initial panel is normal.

Symptoms, Risk Factors, and Patient Scenarios

The examples below organize common testing questions. A symptom does not confirm a disease, and the same symptom may have several unrelated causes.

Symptom or situation	What may be considered	Possible tests, next steps, and safety limits
Persistent diarrhea	Infection, celiac disease, inflammatory bowel disease, medication effect, microscopic colitis, malabsorption, pancreatic insufficiency, lactose intolerance, or IBS with diarrhea.	A focused starting set may include CBC, CMP, tTG-IgA with Total IgA, CRP, Fecal Calprotectin, and targeted pathogen testing. Blood, high fever, severe pain, faintness, or dehydration needs prompt care.
Bloating, gas, or bowel-pattern change without warning signs	Dietary fermentation, constipation, lactose intolerance, celiac disease, small intestinal bacterial overgrowth in selected clinical settings, or a disorder of gut-brain interaction.	Consider focused celiac testing and the Lactose-Intolerance Testing category when the history supports it. History, examination, dietary review, and selected breath testing may be more useful than a broad panel. Weight loss, anemia, bleeding, nocturnal symptoms, or progressive pain requires evaluation.
Upper abdominal burning, ulcer history, or unexplained iron deficiency	H. pylori, ulcer disease, medication injury, reflux, gastritis, bleeding, or another upper-GI disorder.	Consider H. pylori Stool Antigen or Urea Breath Test, plus CBC and iron studies when bleeding is possible. Alarm features may require upper endoscopy. Black stool, bloody vomit, dizziness, or sudden severe pain needs urgent care.
Visible blood in stool or black, tarry stool	Hemorrhoids, fissure, ulcer, diverticular bleeding, inflammatory bowel disease, polyps, cancer, medication-related bleeding, or another source.	CBC and selected metabolic or coagulation testing may assess consequences, but FIT is not a substitute for diagnostic evaluation. Prompt examination, endoscopy, colonoscopy, or imaging may be required.
Greasy or difficult-to-flush stool, weight loss, or fat-soluble vitamin deficiency	Exocrine pancreatic insufficiency, celiac disease, small-bowel disease, bile-flow problems, or another malabsorptive disorder.	Consider Pancreatic Elastase-1, selected Fecal Fat, CMP, iron, B12, folate, vitamin D, and celiac testing. Imaging, endoscopy, or specialist evaluation may be needed. Rapid weight loss, jaundice, or severe pain warrants prompt assessment.
Acute severe upper-abdominal pain with nausea or vomiting	Acute pancreatitis, gallbladder disease, ulcer complication, obstruction, cardiac disease, vascular disease, or another urgent cause.	This is not a routine self-testing scenario. Prompt examination may include Lipase, selected Amylase, liver-associated tests, imaging, ECG, or other emergency evaluation.
Persistent constipation or slowed bowel pattern	Dietary factors, dehydration, medication effects, pelvic-floor dysfunction, obstruction, metabolic disturbance, or hypothyroidism.	When thyroid-compatible symptoms, thyroid history, or autoimmune risk is present, consider TSH with selected Free T4. A CMP may add metabolic context. Severe pain, vomiting, distension, or inability to pass stool or gas requires urgent evaluation.²⁸
Frequent bowel movements with weight loss, heat intolerance, tremor, or palpitations	Hyperthyroidism, infection, medication or stimulant effects, anxiety, inflammatory disease, malabsorption, or another systemic process.	Targeted TSH and Free T4 may be appropriate alongside symptom-directed digestive testing. A very rapid or irregular heartbeat, chest pain, fainting, severe weakness, or confusion requires prompt care.²⁷
Unexplained iron deficiency, B12 or folate deficiency, or low vitamin D	Dietary insufficiency, blood loss, celiac disease, gastric disease, medication effects, pancreatic insufficiency, small-bowel disease, or more than one cause.	Use focused Ferritin, Iron, and TIBC, Vitamin B12 and Folate, Vitamin D, and celiac testing. A deficiency result does not establish the cause; bleeding and malabsorption may need evaluation.
Recent antibiotics followed by new diarrhea	Antibiotic-associated diarrhea, C. difficile, another infection, medication effect, or an unrelated bowel disorder.	Testing should be limited to a compatible diarrheal illness. The C. difficile Toxin B Test or another clinician-selected algorithm may be considered. Formed stool and asymptomatic testing increase the risk of detecting colonization rather than disease.¹¹

How Digestive Tests Are Used

A test’s usefulness depends on the clinical question, not its price, novelty, or panel size. Use-status labels describe the setting in which a test may be helpful; they are not ratings of quality.

Common or First-line

Broad tests used to assess complications or establish a baseline, such as CBC and CMP. They are not necessarily required for every mild symptom.

Targeted or Risk-based

Tests selected because the symptom pattern, exposure, medication, family history, or prior result supports a specific question, such as celiac serology, calprotectin, H. pylori, pancreatic elastase, or thyroid testing.

Monitoring

Repeated testing used to follow a known diagnosis, documented deficiency, treatment response, or prior abnormality. Monitoring should not become an automatic broad panel on a fixed schedule.

Specialist-directed

Tests or procedures whose selection and interpretation often depend on gastroenterology, allergy, endocrinology, radiology, pathology, or another specialty, including biopsy, HLA testing, and specialized pancreatic or motility evaluation.

Emerging or Insufficiently Validated

Commercial microbiome scores, intestinal-permeability panels, generalized cytokine panels, and some direct-to-consumer metabolomic tests may lack sufficient standardization, actionability, or outcome evidence for routine care.

Not for Broad Routine Screening

Examples include amylase or lipase without a pancreatic indication, tumor markers for general digestive-cancer screening, universal pathogen panels, food-IgG panels, or ASCA/ANCA used as stand-alone IBD tests.

Six digestive-testing categories: common or first-line, targeted or risk-based, monitoring, specialist-directed, emerging, and not for broad routine screening. — A digestive test’s usefulness depends on the clinical question. Larger or more expensive panels are not automatically more informative, and use status describes context rather than quality or price.

Detailed Digestive Health Test Guide

The tables below summarize common uses and limitations. A result described as high, low, positive, negative, detected, or not detected has meaning only in relation to the specimen, method, unit, laboratory reference information, preparation, patient context, and related findings.

Foundational and Targeted Blood Tests

Test and quick facts	What it shows and how it is used	Preparation, influences, and limitations
Complete Blood Count with Differential and Platelets CBC, CBC with differential First-line	Measures red blood cells, hemoglobin, hematocrit, red-cell indices, white blood cells, and platelets. It may be used to look for anemia patterns, infection-related changes, inflammation-associated findings, or complications of blood loss. Low hemoglobin supports an anemia pattern, while white-cell and platelet changes remain nonspecific.	Blood test; fasting is usually not needed when ordered alone. Hydration, pregnancy, altitude, recent illness, bleeding, medicines, and laboratory method can affect results. A CBC cannot identify the cause or location of bleeding, anemia, inflammation, or infection by itself.¹⁷
Comprehensive Metabolic Panel CMP, chemistry panel First-line	Measures selected electrolytes, kidney markers, glucose, calcium, proteins, bilirubin, and liver-associated enzymes. It may help assess dehydration, electrolyte disturbance, albumin, bilirubin, kidney context, and liver-related patterns. The pattern is usually more informative than one isolated result.	Follow the order and laboratory instructions because fasting may be needed for accompanying tests. Hydration, exercise, alcohol, hemolysis, medicines, supplements, acute illness, and fasting status can affect results. A CMP cannot establish a bowel, gallbladder, bile-duct, liver, or pancreatic diagnosis by itself.¹⁸
C-Reactive Protein Test CRP TargetedMonitoring	Measures a liver-produced protein that increases with many inflammatory states. It can provide systemic context for possible IBD, infection, or another inflammatory condition. A high result supports inflammation but does not identify the source; a normal value does not exclude localized intestinal disease.	Fasting is usually unnecessary when ordered alone. Infection, injury, surgery, inflammatory disease, pregnancy, obesity, and medicines can affect results. CRP cannot diagnose IBD or locate inflammation by itself.¹⁹
Sedimentation Rate Test ESR, sed rate TargetedMonitoring	Measures how quickly red blood cells settle in a tube. It is an indirect inflammatory marker influenced by blood-cell characteristics. A high result can occur with inflammation, anemia, pregnancy, age-related changes, kidney disease, or other conditions.	Fasting is usually unnecessary when ordered alone. Anemia, red-cell shape, age, pregnancy, kidney disease, technical factors, and medicines can affect the result. ESR cannot identify the cause, site, or severity of intestinal disease by itself.²⁰
Ferritin, Iron, and Total Iron Binding Capacity Panel Iron studies, iron panel, transferrin saturation TargetedMonitoring	Assesses stored iron, circulating iron, binding capacity, and calculated iron availability. It may help evaluate iron depletion, anemia, chronic blood loss, inflammation, or malabsorption. Low ferritin commonly supports depleted iron stores, but ferritin may be normal or elevated during inflammation.	Follow product-specific fasting and timing instructions and disclose supplements. Inflammation, recent iron intake, time of day, menstruation, bleeding, liver disease, and supplements can affect results. Iron studies cannot identify the source of blood loss or the reason iron is low by themselves.²¹
Vitamin B12 and Folate Panel Cobalamin, B12, folate TargetedMonitoring	Measures circulating vitamin B12 and folate status. It may be used when macrocytic anemia, neuropathy, dietary risk, gastric disease, medication effects, celiac disease, or small-bowel malabsorption is possible. Borderline B12 results may require confirmatory markers or cause evaluation.	Follow product instructions and disclose supplements or injections. Supplements, fortified foods, pregnancy, kidney or liver disease, and method can affect results. The panel cannot determine whether the cause is diet, pernicious anemia, celiac disease, medication use, or another disorder by itself.²²
Vitamin D, 25-Hydroxy, Total 25-OH vitamin D TargetedMonitoring	Assesses vitamin D status when deficiency, bone risk, restricted intake, celiac disease, pancreatic insufficiency, or another malabsorptive condition is a concern.	Disclose vitamin D supplements and dose. Season, sun exposure, body composition, liver and kidney function, supplementation, and assay method can affect results. A low value does not identify the cause of deficiency by itself.
Magnesium and Zinc Targeted	May add information when prolonged diarrhea, restricted intake, malabsorption, major gastrointestinal surgery, or documented deficiency risk is present.	Supplements, timing, inflammation, albumin, kidney function, and specimen quality can influence interpretation. Serum measurements may not fully represent total body stores, and broad micronutrient screening without a defined question can create incidental findings.
TSH and Free T4 Test Thyroid-function screening pair TargetedNot always needed	TSH measures pituitary signaling to the thyroid; Free T4 measures unbound thyroxine. The pair may help evaluate persistent constipation, frequent bowel movements, unexplained weight change, heat or cold intolerance, palpitations, known thyroid disease, or autoimmune clustering when the history supports a thyroid question.	Fasting is often unnecessary unless other tests require it. Pregnancy, acute illness, pituitary disease, thyroid medicines, other medicines, biotin and supplements, collection timing, and assay interference can affect results. It is not routine screening for every digestive symptom and cannot identify a GI cause.²⁶
Liver Function Panel, Hepatic Function Panel with GGT, and Direct Bilirubin TargetedMonitoring	Provides selected enzyme, bilirubin, and protein patterns relevant to liver, gallbladder, and bile-flow questions. The pattern may help distinguish hepatocellular, cholestatic, or mixed abnormalities and guide the need for imaging or further testing.	Alcohol, exercise, medicines, supplements, hemolysis, acute illness, and fasting can affect results. Blood tests do not directly visualize gallstones, bile-duct obstruction, or liver tissue and cannot determine the cause of an abnormal pattern by themselves.

Celiac Disease Blood Tests

Test and quick facts	What it shows and how it is used	Preparation, influences, and limitations
Tissue Transglutaminase IgA Antibody Test tTG-IgA, TTG IgA First-lineMonitoring	Measures IgA antibodies directed against tissue transglutaminase. It is the preferred initial serologic test for most people being evaluated for celiac disease. A positive result raises suspicion; a negative result is less reassuring when gluten intake is low, IgA is deficient, disease is mild, or suspicion remains high.	The person generally needs to be eating gluten for informative serology. Gluten restriction, IgA deficiency, immunosuppression, age, intestinal damage, and method can affect results. tTG-IgA does not complete every adult diagnosis by itself.²³
IgA Test Total IgA, quantitative IgA Targeted companion	Measures the total concentration of IgA, not a celiac-specific antibody. It helps determine whether IgA-based celiac tests are interpretable. A low value may make tTG-IgA and EMA-IgA falsely negative and can prompt an IgG-based strategy.	Fasting is usually unnecessary. Immunodeficiency, medicines, protein loss, liver disease, and laboratory method can affect the value. Total IgA cannot diagnose celiac disease by itself.
Endomysial IgA Antibody Screen with Reflex to Titer EMA-IgA TargetedConfirmatory serology	Measures IgA antibodies against endomysial targets, commonly by immunofluorescence. It can increase serologic confidence after or alongside tTG-IgA in selected situations. A positive value strongly supports celiac-type autoimmunity in the appropriate context.	Continue medically appropriate gluten intake until the diagnostic plan is complete. Gluten restriction, IgA deficiency, mild disease, reader interpretation, and method can affect results. EMA-IgA cannot determine whether an individual needs biopsy by itself.
Deamidated Gliadin Peptide IgG and IgA Antibodies DGP-IgG, DGP-IgA TargetedSpecialist-directed	Measures antibodies to deamidated gliadin peptides. It may be useful with IgA deficiency, in some young children, or as part of a specialist-selected strategy. It is generally less preferred than tTG-IgA for initial testing in most IgA-sufficient adults.	Testing should occur while consuming gluten unless a specialist directs otherwise. Age, IgA status, other digestive disease, gluten restriction, and method can affect results. DGP antibodies do not diagnose celiac disease or non-celiac gluten sensitivity by themselves.
Tissue Transglutaminase IgG Antibody Test tTG-IgG TargetedSpecialist-directed	Provides an IgG-based celiac-associated antibody option, especially when confirmed IgA deficiency makes IgA-based testing unreliable.	Gluten exposure still matters. It is not interchangeable with tTG-IgA for routine first-line testing in IgA-sufficient adults, and a positive result needs clinical correlation.
HLA Typing for Celiac Disease HLA-DQ2, HLA-DQ8 TargetedSpecialist-directed	Evaluates genetic variants strongly associated with celiac susceptibility. It may help exclude celiac disease in selected uncertain cases, including some people already eating gluten-free. Absence of relevant variants makes celiac disease very unlikely.	Gluten exposure is not required for genetic testing. A compatible HLA result is common in the general population and does not show active disease, intestinal injury, or the need for treatment.

Older Anti-Gliadin Antibody Terminology

Older medical records may list native anti-gliadin antibody testing as AGA. These older AGA tests are less specific than currently preferred celiac serology and should not be confused with deamidated gliadin peptide, or DGP, antibody testing. Historical results should be reviewed in the context of the assay used, gluten exposure, total IgA, symptoms, and any biopsy findings.

Stool, Breath, Infection, and Pancreatic Tests

Test and quick facts	What it shows and how it is used	Preparation, influences, and limitations
Calprotectin Stool Test Fecal calprotectin, FC TargetedMonitoring	Measures calprotectin released mainly by activated neutrophils in the intestinal tract. It may help distinguish intestinal inflammation from a functional disorder and monitor selected patients with known IBD. A higher result supports inflammation; a lower result makes active neutrophilic inflammation less likely in the right setting.	No fasting; follow collection and storage instructions. Infection, NSAID use, bleeding, age, collection quality, and method can affect results. It cannot determine the cause of inflammation by itself.⁷
Lactoferrin, Quantitative, Stool Fecal lactoferrin TargetedMonitoring	Measures a neutrophil-associated protein in stool. It may add evidence of intestinal inflammation in selected diarrhea or IBD contexts.	Collection and handling instructions matter. Infection and other inflammatory conditions may raise the value. Lactoferrin does not diagnose the cause or replace endoscopy when tissue evaluation is needed.
FIT Test or Fecal Globin by Immunochemistry FIT, iFOBT Risk-based screening	Detects human hemoglobin from lower-GI bleeding. It is one guideline-supported colorectal-cancer screening option for eligible adults without symptoms. A positive result requires colonoscopy.	Follow the kit. FIT generally requires no dietary restriction. Intermittent bleeding, collection quality, handling, and lesion location can affect results. A negative result does not evaluate visible bleeding or permanently rule out cancer.¹⁵
Helicobacter pylori Antigen Stool Test H. pylori stool antigen TargetedMonitoring	Detects antigen from active H. pylori infection. It may be used to evaluate active infection or confirm eradication after appropriately timed treatment.	Proton-pump inhibitors, potassium-competitive acid blockers, antibiotics, bismuth, recent treatment, and sample handling can affect accuracy. It cannot show ulcer location, cancer, or the cause of all upper-GI symptoms by itself.⁹
Helicobacter pylori Urea Breath Test UBT TargetedMonitoring	Measures urease activity consistent with active H. pylori. It may detect active infection or document eradication after treatment.	Follow exact fasting, medication, and timing instructions. Acid suppressors, antibiotics, bismuth, food, recent treatment, and collection technique can affect results. It cannot determine ulcer severity or whether endoscopy is needed.
Gastrointestinal Pathogen Panel or Gastrointestinal Pathogen Panel, Real-Time PCR Multiplex GI panel, stool PCR Targeted	Detects selected bacterial, viral, and parasitic genetic targets, depending on the panel. It may be useful when diarrhea is severe, prolonged, bloody, febrile, travel-related, outbreak-associated, immunocompromised, or clinically consequential.	Submit the correct stool specimen promptly and follow transport instructions. Antibiotics, formed versus diarrheal stool, transport, contamination, and method matter. Molecular detection may represent nonviable organisms or colonization, and more than one target may be detected.¹⁰
Ova and Parasites Stool Examination O&P, concentrated and permanent smear Targeted	Microscopically evaluates stool for selected parasites or parasite-related findings. It may be considered with relevant travel, exposure, persistent diarrhea, eosinophilia, immune status, or epidemiologic risk.	Number and timing of specimens, preservatives, recent antiparasitic therapy, and transport can affect yield. A single negative specimen may not exclude intermittent shedding, and O&P does not detect every pathogen.
Salmonella/Shigella Culture, Campylobacter EIA, and Shiga Toxin with Reflex Targeted culture, antigen, and toxin testing Targeted	Looks for selected bacterial pathogens or toxins in compatible diarrheal illness. Culture can detect viable organisms and may enable additional public-health or susceptibility work in selected cases.	Prompt diarrheal-stool collection, transport, antibiotic exposure, and specimen quality matter. A negative result does not exclude pathogens outside the test menu.
Clostridioides difficile Toxin B, Qualitative C. difficile, C. diff Targeted	Assesses a toxin-related target in a compatible diarrheal illness, especially after antibiotic or healthcare exposure when the clinical picture supports testing.	Testing formed stool or asymptomatic people increases the risk of detecting colonization rather than disease. The laboratory’s acceptance criteria and the full testing algorithm matter.¹¹
Pancreatic Elastase-1 Fecal elastase, FE-1 Targeted	Measures a pancreatic enzyme marker in stool and is a preferred initial test when exocrine pancreatic insufficiency is suspected. A low value may support reduced exocrine output in a compatible clinical setting.	Use solid or semisolid stool when possible because watery stool can cause dilution and a falsely low value. Mild disease and low pretest probability reduce performance. It does not identify the cause, pancreatic anatomy, or acute pancreatitis.¹²¹³
Fecal Fat, Qualitative, Stool Qualitative fecal fat, Sudan stain TargetedSpecialist-directed	Evaluates excess fat in stool when steatorrhea, weight loss, or fat-soluble vitamin deficiency raises concern for malabsorption. An abnormal result supports fat malabsorption.	Requirements differ from timed quantitative fecal-fat testing. Diet, medicines, laxatives, contamination, and method can affect results. It cannot identify whether the cause is pancreatic, biliary, or small-intestinal by itself.
Lactose-Intolerance Testing Hydrogen breath testing may be used in selected settings TargetedAvailability varies	A lactose hydrogen breath test measures exhaled gas after a measured lactose load. A rise with compatible symptoms supports lactose malabsorption, although symptoms and results do not always match.	Follow the testing center’s exact diet, fasting, smoking, exercise, oral-hygiene, antibiotic, and bowel-preparation instructions. It does not diagnose milk allergy or determine that all dairy must be avoided.¹⁴
Lipase Test and Amylase Test Pancreatic enzymes Targeted acute-care context	Measures circulating digestive enzymes, with lipase generally more useful for suspected acute pancreatitis. Marked elevation may support acute pancreatic injury when symptoms are compatible, but elevation can occur for other reasons.	Severe acute pain and vomiting require prompt clinical evaluation rather than delayed routine testing. Timing, kidney function, medicines, salivary disease, macroenzymes, and method can affect results. These tests do not diagnose chronic pancreatitis or exocrine insufficiency.²³

Comparison of blood lipase and amylase, stool pancreatic elastase, fecal fat testing, and imaging or endoscopy for different pancreatic questions. — Lipase and amylase, pancreatic elastase, fecal fat, and imaging answer different questions about acute pancreatic injury, exocrine output, malabsorption, and anatomy. None identifies every pancreatic condition by itself.

Digestive Symptom-to-Test Pathway

This is an educational framework, not a diagnostic or treatment algorithm.

Screen for urgency first. Visible or black stool, vomiting blood, severe or rapidly worsening pain, persistent vomiting, jaundice, fainting, marked distension, high fever, confusion, or dehydration should prompt urgent professional evaluation rather than routine self-directed testing.
Define the dominant pattern. Clarify whether the main concern is diarrhea, constipation, upper-GI discomfort, bleeding, weight loss, greasy stool, nutrient deficiency, fever, bowel-pattern change with thyroid-compatible symptoms, or monitoring after treatment.
Review duration and context. Acute illness after travel or food exposure follows a different pathway from months of bloating, chronic iron deficiency, symptoms after gluten, recent antibiotics, thyroid history, or symptoms after pancreatic surgery.
Look for warning features and risk. Consider age, family history, anemia, weight loss, nocturnal symptoms, fever, immune suppression, recent antibiotics, medication effects, prior GI surgery, known digestive disease, and autoimmune clustering.
Choose the smallest test set that answers a defined question.
- General complications: CBC, CMP, and focused nutrient testing.
- Celiac concern: tTG-IgA plus Total IgA while consuming gluten; add IgG-based, EMA, or HLA testing only when indicated.
- Inflammatory diarrhea: Fecal Calprotectin or Fecal Lactoferrin, CRP, CBC, and targeted pathogen testing.
- Infectious diarrhea: select stool testing according to severity, duration, exposure, immune status, outbreak concern, and how the result would change management.
- Upper-GI symptoms or ulcer risk: active-infection H. pylori Stool Antigen or Urea Breath Test when appropriate; use endoscopy for alarm features.
- Greasy stool or malabsorption: Pancreatic Elastase-1, selected Fecal Fat and nutrient tests, celiac evaluation, and imaging when indicated.
- Acute pancreatic-type pain: prompt evaluation with Lipase and imaging as appropriate.
- Thyroid-compatible bowel changes: targeted TSH with selected Free T4; continue digestive evaluation when symptoms or warning signs require it.
- Average-risk colorectal screening: use a guideline-supported option such as annual FIT or colonoscopy according to age, history, and preference.
Plan the next step before ordering. Ask what a positive, negative, borderline, or discordant result would change and whether confirmation requires repeat testing, imaging, endoscopy, colonoscopy, biopsy, or specialist review.

Comparison of blood, stool, breath, endoscopy with biopsy, and imaging for digestive health evaluation. — Blood, stool, breath, endoscopy, biopsy, and imaging reveal different types of information. A normal blood result does not rule out structural or tissue disease.

Blood Versus Stool Versus Breath Versus Endoscopy

Method and examples	Best suited to reveal	Advantages, limitations, and next method
Blood testing CBC, CMP, CRP, ESR, iron studies, B12, folate, celiac antibodies, thyroid tests, lipase.	Whole-body effects, immune response, anemia, inflammation, dehydration, nutrients, thyroid function, liver-associated patterns, and pancreatic-enzyme elevation.	Blood collection is familiar and can evaluate several systemic complications at once. Findings are often indirect and nonspecific. Use stool testing, imaging, endoscopy, or biopsy when the question involves intestinal inflammation, pathogens, bleeding source, anatomy, or tissue diagnosis.
Stool testing Calprotectin, pathogen tests, FIT, Pancreatic Elastase, Fecal Fat.	Signals originating in or passing through the intestinal tract, including inflammatory proteins, occult blood, pathogens, pancreatic exocrine output, and excess fat.	Stool markers are more organ-proximal for several GI questions. Collection, consistency, handling, and timing matter; intermittent findings may be missed. Endoscopy, imaging, or repeat testing may be needed to localize or confirm a result.
Breath testing H. pylori Urea Breath Test, selected lactose or carbohydrate tests.	Urease activity or microbial gas production after a test substrate.	Noninvasive and function-focused, but highly preparation-sensitive. False-positive and false-negative results occur, and a positive result may not explain every symptom. Use stool tests, dietary assessment, imaging, or endoscopy when alternative or structural disease is possible.
Endoscopy and biopsy Upper endoscopy, colonoscopy, duodenal biopsy, gastric biopsy, intestinal biopsy.	Directly visible ulcers, polyps, inflammation, tumors, bleeding sites, villous injury, and microscopic tissue changes.	Allows direct inspection and tissue sampling, but is invasive, requires preparation, and has procedural risks. Imaging may be needed for areas beyond reach, while blood and stool tests may assess systemic effects and longitudinal change.
Imaging and functional studies Ultrasound, CT, MRI, MRCP, gastric-emptying studies, transit studies, selected motility tests.	Anatomy, obstruction, gallstones, bile ducts, pancreas, masses, wall thickening, transit, or organ function not directly measured by routine laboratory tests.	Can evaluate regions beyond endoscopic reach or answer a specific functional question. Imaging may expose a patient to contrast or radiation and may still require endoscopy, biopsy, or laboratory testing for confirmation and context.

Celiac Test Crosswalk

Test and main question	Typical role and when useful	Important limitation and gluten requirement
tTG-IgA Are celiac-associated IgA autoantibodies present?	Preferred initial serology for most patients with compatible symptoms, iron deficiency, osteoporosis risk, autoimmune association, or family history.	May be falsely negative with IgA deficiency, reduced gluten exposure, immunosuppression, or mild disease. Gluten intake generally matters.
Total IgA Is enough IgA present for IgA-based celiac tests to be reliable?	Interpretive companion to tTG-IgA, especially during initial testing or when negative IgA serology conflicts with meaningful suspicion.	It is not a celiac-specific antibody. Gluten intake does not affect total IgA itself, but it affects the accompanying celiac antibodies and biopsy.
EMA-IgA Can a highly specific second IgA antibody increase confidence?	Selected confirmatory serology after or alongside a positive tTG-IgA pattern.	More technique- and reader-dependent and affected by IgA deficiency and gluten restriction. Gluten intake generally matters.
DGP-IgG or tTG-IgG Can an IgG-based strategy help?	Selected alternative serology when IgA deficiency is confirmed and in some pediatric or specialist-directed situations.	IgG tests are not interchangeable with tTG-IgA in IgA-sufficient adults. Gluten intake generally matters.
HLA-DQ2/DQ8 Is the genetic background compatible with celiac disease?	An exclusion tool in uncertain cases, including prior gluten removal, discordant serology and biopsy, or an uncertain historical diagnosis.	A compatible result is common and does not diagnose celiac disease. Gluten exposure is not required.
Upper endoscopy with duodenal biopsies Is characteristic small-intestinal tissue injury present?	Diagnostic confirmation in many adults after positive serology, high clinical suspicion, or unresolved discordance.	Sampling and pathology interpretation matter. Prior gluten restriction can reduce yield, so gluten intake generally matters in diagnostic pathways.

Do Not Begin a Gluten-Free Diet Before Celiac Testing Without Professional Guidance

Celiac antibody concentrations and small-intestinal injury can decline after gluten is removed. Starting a gluten-free diet before blood testing or biopsy may therefore produce a false-negative or less conclusive result. This can make it harder to distinguish celiac disease from wheat allergy, non-celiac gluten sensitivity, IBS, or another cause of symptoms.

A person who has already stopped gluten should not deliberately restart it without discussing the risks and diagnostic plan with a qualified clinician. The next step may involve prior-record review, HLA Typing, professionally supervised gluten exposure, repeat serology, or endoscopy. The appropriate approach depends on symptoms, nutritional status, pregnancy, age, and the possibility of a severe reaction or another diagnosis.

Fecal calprotectin framework showing overlapping digestive symptoms, a possible intestinal inflammatory signal, and a functional condition that may remain possible. — Fecal calprotectin can signal intestinal inflammation, but it does not identify the cause by itself. Normal markers do not dismiss warning signs or replace clinical assessment.

Inflammatory Versus Functional Digestive Patterns

Feature	Inflammatory pattern	Functional pattern and key cautions
Examples	Crohn’s disease, ulcerative colitis, selected infections, celiac disease, and microscopic colitis may produce inflammatory or tissue findings.	IBS and functional bloating involve symptoms without the same routine pattern of destructive inflammation. A patient can have more than one condition.
Common clues	Blood in stool, nocturnal diarrhea, fever, weight loss, anemia, high calprotectin, growth concerns, or family history may increase concern.	Recurrent abdominal pain related to defecation with altered stool form or frequency may fit a disorder-of-gut-brain-interaction pattern when warning signs are absent. Symptoms alone do not establish either category.
Role of blood inflammation tests	CRP or ESR may be elevated, but normal values do not exclude intestinal inflammation.	IBS itself generally does not elevate CRP or ESR. These markers remain nonspecific and should not be used as stand-alone diagnostic tests.
Role of fecal calprotectin	Fecal Calprotectin is often higher with active neutrophilic intestinal inflammation and can support decisions about further evaluation or monitoring.	It is usually lower when active intestinal inflammation is absent, but infection, NSAIDs, age, and other diseases can elevate it. A low result does not override warning signs.
Can one blood test diagnose IBS?	Not applicable; inflammatory diseases require their own diagnostic pathways.	No. IBS is assessed from a characteristic symptom pattern after appropriate evaluation of warning signs and selected alternatives. Broad “IBS blood panels” should not replace clinical assessment.⁴⁵

Individual Digestive Tests Versus Panels

Testing option	When it may be useful	Advantages, limitations, and questions to ask
Single test One defined marker such as tTG-IgA, calprotectin, lipase, FIT, TSH, or pancreatic elastase.	When there is one clear question and any required companion test is understood.	Focused and less likely to generate unrelated findings, but may be incomplete when interpretation requires a companion test, such as tTG-IgA with Total IgA. Ask whether the test answers the question by itself.
Small, purpose-built panel Related tests such as TSH and Free T4, Ferritin, Iron, and TIBC, or a focused celiac panel.	When the components jointly answer a defined diagnostic-support or monitoring question.	May reduce missing context and simplify ordering. Components and reflex rules vary. Review exactly what is included and what a borderline or discordant result would change.
Broad symptom panel Multiple blood, nutrient, inflammatory, liver, pancreatic, or antibody tests.	Only when each component maps to the symptom pattern and there is a follow-up plan.	Can assess several plausible complications but may miss the correct stool, breath, imaging, or endoscopic test and can generate incidental abnormalities. Ask which components are necessary.
Multiplex stool pathogen panel	Selected severe, prolonged, bloody, immunocompromised, outbreak, or public-health contexts.	Detects many targets quickly, but can identify colonization, nonviable organisms, or multiple targets and may not provide susceptibility information. Ask whether targeted testing would be more appropriate.
Commercial microbiome, food-IgG, or permeability panel	Generally not for routine diagnosis	May generate exploratory data but often has limited standardization, uncertain clinical utility, and risk of unnecessary restriction or treatment. Ask whether the method is validated, guideline-supported, and likely to improve outcomes.²⁴

Panel verification note: Review the live product page immediately before ordering because panel names, components, reflex rules, specimen requirements, preparation, and availability may change.

Digestive Test Names and Abbreviations

Name and abbreviation	What it refers to	Do not confuse it with
Complete Blood Count CBC, CBC with differential	Blood-cell counts and indices.	A blood smear or iron studies, which answer different questions.
Comprehensive Metabolic Panel CMP	A group of metabolic, kidney, protein, bilirubin, and liver-associated measurements.	A branded digestive “comprehensive” panel, which may contain different components.
C-Reactive Protein CRP	A nonspecific systemic inflammation marker.	High-sensitivity CRP, commonly used for cardiovascular-risk assessment.
Tissue Transglutaminase IgA tTG-IgA, TTG IgA	The preferred initial celiac-associated antibody for most patients.	Total IgA, which checks IgA quantity rather than celiac autoimmunity.
Deamidated Gliadin Peptide DGP-IgA, DGP-IgG	Selected celiac-associated antibodies to deamidated gliadin peptides.	Older native anti-gliadin antibody, or AGA, tests.
Fecal Calprotectin FC, stool calprotectin	An intestine-focused inflammatory marker.	Serum calcium or calcitonin.
Fecal Immunochemical Test FIT, iFOBT	A stool test for human hemoglobin used in colorectal screening.	Evaluation of visible rectal bleeding or black stool.
Gastrointestinal Pathogen Panel GI PCR panel, multiplex GI panel	A molecular panel detecting selected pathogen targets.	A stool culture, which detects viable organisms and may permit additional testing.
Pancreatic Elastase-1 FE-1, fecal elastase	A stool marker of pancreatic exocrine output.	Blood lipase or amylase used in acute pancreatic evaluation.
Urea Breath Test UBT	A breath test for active H. pylori urease activity.	Hydrogen or methane breath testing for lactose malabsorption or selected SIBO questions.

Preparation and Interference Matrix

Preparation varies by test, laboratory method, medicine, and collection kit. Never stop a prescription or nonprescription medicine solely because of general online guidance. Confirm the plan with the prescribing professional and performing laboratory.

Factor and tests commonly affected	How results may be altered	General preparation and caution
Gluten restriction tTG-IgA, EMA-IgA, DGP antibodies, duodenal biopsy	Antibody concentrations and intestinal injury may decline, causing false-negative or less conclusive testing.	Complete the diagnostic plan while eating a medically appropriate gluten-containing diet unless a qualified clinician directs otherwise. Do not restart gluten independently after a severe reaction or prolonged avoidance.
Low Total IgA tTG-IgA and EMA-IgA	IgA-based celiac tests may be falsely negative.	Pair initial celiac serology with Total IgA when appropriate. Use an IgG-based strategy under professional guidance when IgA deficiency is present.
Fasting CMP when bundled with glucose or lipids, some iron studies, urea breath and carbohydrate breath tests	Food may alter glucose, triglycerides, iron, and breath-test substrate handling.	Follow the exact instructions for the entire order, not one component. People with diabetes, pregnancy, frailty, or a history of hypoglycemia should discuss fasting safety.
Hydration CBC, CMP, kidney markers, proteins	Dehydration may concentrate some blood values; excess fluid can dilute them.	Maintain usual hydration unless specifically instructed. Persistent vomiting or inability to retain fluids requires clinical assessment.
Acid-suppressing medicine H. pylori stool antigen and urea breath testing	Proton-pump inhibitors or potassium-competitive acid blockers may suppress bacterial activity and cause a false-negative result.	Obtain test-specific instructions. A temporary hold may be required, but do not stop prescribed therapy without guidance, especially with ulcer, bleeding, or severe reflux history.
Antibiotics or bismuth H. pylori, stool culture, pathogen panels, breath tests	May suppress organisms, alter intestinal flora, and reduce test sensitivity.	Report recent use and follow the required waiting period. Proof-of-eradication testing for H. pylori is generally delayed until at least four weeks after antibiotics.⁹
NSAIDs Calprotectin, occult blood testing, CBC	May contribute to mucosal injury, bleeding, or a higher calprotectin result.	Record the medicine, dose, and timing. Do not stop prescribed antiplatelet or pain therapy without professional guidance.
Watery stool Pancreatic elastase	Dilution can produce a falsely low concentration.	Use solid or semisolid stool when possible. A low result from a watery specimen may need confirmation rather than immediate labeling as pancreatic insufficiency.
Formed stool C. difficile testing	Testing without compatible diarrhea increases detection of colonization.	Submit an unformed specimen only when testing criteria are met, unless a clinician directs otherwise.
Contamination or delayed transport Pathogen tests, calprotectin, FIT, fecal fat, elastase	Urine, toilet water, chemicals, incorrect temperature, delay, or mixed specimens may distort or invalidate results.	Use the supplied collection device and follow transfer, labeling, storage, and shipping directions. Contact the laboratory rather than submitting a visibly contaminated specimen.
Recent bowel preparation or colonoscopy Stool microbiology, calprotectin, breath tests, fecal fat	May temporarily change microbiota, dilute stool, or alter bowel function.	Ask how long to wait before a routine specimen. Do not delay urgent evaluation for a suspected complication.
Smoking, exercise, diet, or oral hygiene Hydrogen and methane breath tests	May change breath-gas production or sample quality.	Follow the testing center’s exact pretest diet, fasting, smoking, exercise, and oral-hygiene rules. Protocols are not interchangeable.
Recent illness, medicines, and supplements CRP, ESR, ferritin, CBC, CMP, calprotectin, nutrient tests, thyroid immunoassays	May create transient inflammatory, metabolic, blood-count, nutrient, or analytical changes.	Disclose illness timing, all medicines, iron, B12, folate, biotin, and other supplements. Never change therapy solely to obtain a preferred laboratory value.

What to Track Before Digestive Testing or Follow-Up

A brief symptom and testing record can make results easier to interpret and can help distinguish an isolated value from a meaningful pattern.

When symptoms began and whether they are continuous, intermittent, worsening, or linked to a particular event.
Stool frequency, consistency, color, and any visible blood or mucus.
The location, timing, duration, and severity of abdominal pain.
Foods, meals, travel, illness, antibiotics, or other medicines associated with the symptoms.
Unintentional weight change, fever, fatigue, appetite change, nighttime symptoms, or reduced exercise tolerance.
Recent antibiotics, acid suppressors, bismuth, laxatives, NSAIDs, antiplatelet medicines, vitamins, and supplements.
Whether gluten was being consumed before celiac testing and whether it had already been restricted.
Whether the blood test was completed fasting or nonfasting and whether collection instructions were followed.
Stool specimen consistency, collection date and time, storage, and transport conditions when relevant.
Treatment start and stop dates, including dietary changes and nutrient replacement.
Previous laboratory results, procedures, imaging, diagnoses, and reference information so trends can be evaluated.

Six-step digestive lab-result pathway covering report verification, clinical context, pattern and trend review, thresholds, confirmation, and escalation. — Interpret digestive lab results with the test, specimen, method, units, preparation, related findings, and prior trends. An abnormal result does not automatically establish disease, and a normal result does not guarantee that serious disease is absent.

How to Understand Digestive Lab Results

Begin with the complete report: test name, specimen, method when shown, value, unit, reference information, flags, collection time, and related tests. Then add the clinical context—symptoms, duration, preparation, medicines, diet, recent illness, previous values, and the reason the test was ordered.

A reference interval describes values observed in a defined reference population. It is not automatically a disease boundary.
A diagnostic threshold is a value or pattern used with other evidence to support or exclude a diagnosis.
A screening cutoff identifies people who should receive another test. A positive screen is not necessarily a diagnosis.
A treatment or monitoring target is a goal used for a known condition and may not match the laboratory reference interval.
Biological variation is normal fluctuation within a person.
Analytical variation comes from the measuring system, and preanalytical variation arises before analysis through preparation, collection, timing, transport, storage, or specimen quality.
Trends may be more useful than one isolated result when the same test and comparable method are used for the same clinical question.
Discordant results deserve explanation. Negative tTG-IgA with very low Total IgA requires a different celiac strategy; low fecal elastase from watery stool may require confirmation; a thyroid result inconsistent with symptoms may require review of illness, timing, medicines, supplements, and assay interference.

For a broader explanation of flags, units, ranges, cutoffs, and trends, use How to Read and Understand Your Lab Results.

Reference Intervals Versus Clinical Decision Thresholds

Term	Meaning and use	Important patient limitation
Laboratory reference interval	A statistical interval for a defined reference population, established through laboratory validation, manufacturer data, or published studies. It flags values outside the stated interval.	An in-range value does not guarantee health, and an out-of-range value does not establish disease. Population, method, specimen, age, sex, and laboratory practices differ.
Diagnostic threshold	A value or pattern that contributes to a disease definition and is combined with symptoms, history, examination, imaging, pathology, or other tests.	Many digestive diagnoses cannot be made from one threshold, and guidelines or populations may differ.
Screening cutoff	A boundary selected to identify people who should receive additional evaluation.	A positive FIT is a signal for colonoscopy, not a cancer diagnosis.
Monitoring target	A goal used to follow a known disorder, complication, or treatment response over time.	Disease phenotype, therapy, risk, and assay differ. Do not change medicine, supplementation, or diet from one result without guidance.
Qualitative result	Positive, negative, detected, not detected, reactive, or nonreactive according to assay-specific signal rules.	“Detected” does not always mean the organism or marker is causing symptoms; colonization, residual nucleic acid, or cross-reactivity may matter.

Fictional Digestive Lab-Result Walkthrough

Educational example only: The findings below are fictional, do not provide universal reference ranges, and do not diagnose a real person.

A fictional adult reports several months of loose stool, fatigue, and unintentional weight loss. The person was eating gluten when tested and had not recently used antibiotics. A clinician ordered a CBC, Ferritin, Iron, and TIBC Panel, tTG-IgA with Total IgA, CRP, and Fecal Calprotectin.

Fictional finding	What the pattern may suggest	What it does not prove and possible follow-up
Hemoglobin and MCV below the sample laboratory intervals	A microcytic anemia pattern that makes iron status and blood loss important questions.	It does not identify the cause or source. Review iron studies, menstrual history, diet, GI symptoms, and bleeding risk.
Ferritin and transferrin saturation below the sample laboratory intervals	Depleted iron stores are likely in this fictional pattern.	It does not distinguish dietary insufficiency, menstrual loss, gastrointestinal loss, or malabsorption.
Positive tTG-IgA with Total IgA within the sample interval	The IgA result is interpretable, and the antibody pattern supports celiac evaluation while gluten was being consumed.	It does not complete every diagnosis. Gastroenterology review and, in many adults, duodenal biopsies may be needed before dietary treatment.
CRP not flagged, but fecal calprotectin elevated	No strong systemic CRP signal at that moment, with a separate intestine-focused inflammatory signal.	It does not identify whether the cause is celiac disease, IBD, infection, medicine-related injury, or another disorder. Warning features may justify stool infection testing, endoscopy, colonoscopy, imaging, or repeat calprotectin.

The key lesson is that related results can strengthen or weaken a hypothesis without turning a laboratory pattern into a complete diagnosis. In this fictional scenario, weight loss and anemia make professional evaluation more important than simply repeating a broad panel.

When Not to Order a Digestive Test

Do not use routine outpatient testing instead of urgent care for severe pain, gastrointestinal bleeding, black stool, persistent vomiting, jaundice, fainting, confusion, marked swelling, or dehydration.
Do not order celiac antibodies after removing gluten and assume a negative result excludes celiac disease. First establish a professional diagnostic plan.
Do not use one inflammation marker to diagnose IBD or one normal marker to dismiss concerning symptoms.
Do not use a blood panel to “diagnose IBS.” IBS has no single confirmatory blood test.
Do not use FIT to evaluate visible blood or black stool. FIT is a screening tool for eligible people without symptoms.
Do not use broad stool pathogen panels for every short, uncomplicated diarrheal episode. Testing should reflect severity, duration, exposure, immune status, outbreak risk, or another defined indication.
Do not test formed stool for C. difficile merely because the organism is a concern. Colonization can produce misleading positive results.
Do not use H. pylori antibody testing to prove active infection or eradication. Stool antigen, urea breath, or selected biopsy-based testing is preferred for those questions.
Do not use Amylase or Lipase as routine wellness screens. They are targeted tests, especially for compatible acute presentations.
Do not label a watery-stool Pancreatic Elastase result as pancreatic insufficiency without considering dilution and confirmation.
Do not use food-IgG, “leaky gut,” proprietary microbiome, or generalized cytokine panels as established substitutes for celiac, food-allergy, IBD, infection, pancreatic, or structural evaluation.
Do not use ASCA or ANCA as stand-alone screening or diagnostic tests for Crohn’s disease or ulcerative colitis.
Do not use tumor markers as general digestive-cancer screening tests.
Do not order TSH and Free T4 automatically for every digestive complaint. Use them when thyroid-compatible symptoms, history, medicines, or autoimmune risk make the question relevant.
Do not duplicate recent testing unless a meaningful trend, treatment response, corrected preparation problem, or change in clinical status is being assessed.

When Repeat or Confirmatory Testing May Be Needed

Initial finding	Why follow-up may be needed	Possible next step
Positive celiac serology	Serology supports but may not complete the diagnosis.	Gastroenterology review and, in many adults, upper endoscopy with duodenal biopsies while gluten is still being consumed.
Negative tTG-IgA with low Total IgA	The IgA-based test may be falsely negative.	DGP-IgG, tTG-IgG, and professional evaluation.
Negative celiac serology with high clinical suspicion	Reduced gluten intake, mild disease, IgA status, immunosuppression, or seronegative celiac disease may complicate interpretation.	Review diet and assay strategy; consider endoscopy or HLA Typing in selected cases.
Positive FIT	FIT detects blood but cannot identify its source.	Diagnostic colonoscopy rather than repeating FIT to see whether the result changes.
Borderline or elevated fecal calprotectin	Infection, NSAIDs, age, method, and transient inflammation may affect the result.	Clinical review, selected pathogen testing, repeat testing, endoscopy, colonoscopy, or imaging depending on level and symptoms.
Low fecal elastase from watery stool	Dilution can create a falsely low concentration.	Repeat on a solid or semisolid specimen and assess symptoms, nutrient status, pancreatic history, and imaging when appropriate.
*Positive H. pylori* test after treatment**	Persistent infection, adherence, reinfection, or unsuitable timing may need clarification.	Review treatment and timing with a professional and use an appropriately timed active-infection test.
*Negative H. pylori* result while using interfering medicines**	Suppression can cause a false-negative result.	Repeat under an appropriate medication and timing plan if suspicion remains.
Detected target on a multiplex stool panel	Detection may represent the cause, colonization, residual nucleic acid, or coinfection.	Clinical correlation, public-health reporting, culture, susceptibility testing, or no additional testing depending on the organism and symptoms.
Unexpected nutrient deficiency	The deficiency may be real, but the cause remains unresolved.	Confirm when indicated and investigate diet, medicines, bleeding, celiac disease, gastric disease, pancreatic insufficiency, or other malabsorption.
Abnormal or discordant TSH and Free T4	Illness, medicines, pregnancy, pituitary disease, supplement interference, collection timing, or thyroid dysfunction may affect the pattern.	Review the complete context, compare prior results, repeat or expand thyroid testing when professionally indicated, and continue GI evaluation when bowel symptoms are not explained.

When Professional or Urgent Care Is Needed

Arrange timely professional review for persistent or worsening digestive symptoms, unexplained anemia, recurrent nighttime symptoms, meaningful unintentional weight loss, fever, a new abdominal mass, progressive swallowing difficulty, recurrent vomiting, a major bowel-pattern change, or symptoms beginning later in life without a clear explanation.

Urgent or Emergency Evaluation May Be Necessary For

Vomiting blood or material resembling coffee grounds.
Black, tarry stool or substantial bright-red bleeding.
Severe, sudden, or rapidly worsening abdominal pain.
Persistent vomiting or inability to keep fluids down.
Fainting, confusion, severe weakness, or signs of shock.
Jaundice, especially with fever or abdominal pain.
Marked abdominal swelling, a rigid abdomen, or inability to pass stool or gas with severe symptoms.
Signs of dehydration, including very low urine output, severe dizziness, dry mouth, or unusual sleepiness.
A very rapid or irregular heartbeat, chest pain, fainting, or severe shortness of breath when bowel changes occur with possible thyroid or systemic symptoms.

Do not delay urgent evaluation to complete a routine laboratory order.

Explore the Digestive and Gastrointestinal Testing Knowledge Center

Focused guide	What it covers	Best next question
How Digestive Symptoms Can Affect Whole-Body Health	Connections among digestive symptoms, blood counts, nutrients, inflammation, and other body systems.	Why can a digestive problem produce fatigue, anemia, skin, bone, or neurologic symptoms?
Nutrient Absorption and Digestive Disorders	Iron, B12, folate, vitamin D, protein, and other patterns related to malabsorption.	Which blood tests can reveal complications of nutrient-absorption problems?
Nutrient Deficiencies Linked to Celiac Disease	Common deficiency patterns before and after a celiac diagnosis.	Which nutrients may need baseline or follow-up testing?
Celiac Disease, Wheat Allergy, and Non-Celiac Gluten Sensitivity Testing	How celiac serology, allergy evaluation, biopsy, genetics, and clinical assessment differ.	What does “gluten intolerance testing” actually mean?
Inflammatory Bowel Disease Testing Beyond Symptoms	Calprotectin, CRP, CBC, nutrients, pathogens, endoscopy, imaging, and monitoring.	How are Crohn’s disease and ulcerative colitis evaluated and monitored?
IBS Testing: What Labs Can and Cannot Rule Out	A limited, symptom-directed rule-out strategy and the role of warning signs.	Is there a blood or stool test that diagnoses IBS?
Lactose Intolerance and Hydrogen Breath Testing	Lactose malabsorption, preparation, symptom correlation, and alternatives.	How is lactose intolerance evaluated?
Pancreatitis: Lipase, Imaging, Causes, and Urgent Symptoms	Acute pancreatic injury and why routine enzyme screening is inappropriate.	When do lipase and amylase help?
Digestive Health After Gallbladder Removal	Post-cholecystectomy symptoms, nutrition, bile-flow context, and selected liver or pancreatic testing.	Which symptoms and tests matter after gallbladder removal?
Blood Tests for Inflammation	CRP, ESR, blood counts, and the limits of nonspecific inflammatory markers.	What can inflammation blood tests reveal, and what can they not locate?

Related Individual Tests and Focused Panels

Use the smallest test or panel that answers a defined question. Review the live product page for current specimen, preparation, components, reflex rules, pricing, and availability.

Pancreatic and Malabsorption Tests

Pancreatic Elastase-1
Fecal Fat, Qualitative, Stool
Lipase and Amylase for a compatible acute pancreatic question, not routine wellness screening
Lactose-Intolerance Testing category; direct breath-test availability and collection protocols may vary

IBD Adjunctive Tests

Saccharomyces cerevisiae IgA Antibodies and Saccharomyces cerevisiae IgG Antibodies, also called ASCA
ANCA Screen with Reflex to ANCA Titer and the Inflammatory Bowel Disease Differentiation Panel

ASCA and ANCA are adjuncts in selected evaluations. They do not diagnose Crohn’s disease or ulcerative colitis by themselves and should not be used for broad routine screening.

Focused Digestive Panels

Digestive Health – Basic and Digestive Health – Advanced
Inflammatory Bowel Disease – Basic
Pancreatic Health Panel
Gallbladder & Digestive Health Panel
Nutrient Absorption & Deficiency Panel – Comprehensive
Gut Health, Food Allergy & Nutrient Balance – Essential, Advanced, and Comprehensive. Review every component and do not assume the largest panel is the best fit.

How Ulta Lab Tests May Help

Where available and after applicable eligibility requirements are met, Ulta Lab Tests allows patients to review available laboratory tests and posted pricing online, place an order, complete specimen collection according to the product instructions, and review results through an online account. Availability, specimen type, collection method, preparation, and timing vary by test and location.

Direct-access testing may provide objective information for a more informed discussion with a qualified healthcare professional. It does not replace examination, diagnosis, endoscopy, imaging, biopsy, emergency care, or treatment guidance.

Explore Digestive System Tests Review How Direct-Access Testing Works

Questions to Ask a Healthcare Professional

Which single clinical question are we trying to answer?
Do my symptoms include warning signs that require imaging, endoscopy, colonoscopy, or urgent evaluation instead of, or in addition to, laboratory testing?
Should I be tested for celiac disease, and am I eating enough gluten for the result to be informative?
Should Total IgA be ordered with tTG-IgA?
Would Fecal Calprotectin add more useful information than a systemic marker for my symptoms?
Is stool pathogen testing indicated based on duration, travel, antibiotic exposure, fever, blood, immune status, or outbreak risk?
Which H. pylori test is appropriate, and how should medicines and timing be managed?
Could my anemia or nutrient deficiency reflect gastrointestinal blood loss, celiac disease, gastric disease, pancreatic insufficiency, or another malabsorptive condition?
Would Pancreatic Elastase-1 be useful, and is the stool specimen suitable?
Could thyroid dysfunction be contributing to constipation, frequent bowel movements, weight change, or other symptoms, or would thyroid testing be low value in my situation?
Do I need colorectal-cancer screening, and which method fits my age, history, risk, and preference?
What will a positive, negative, borderline, or discordant result change?
Which results require repeat testing, imaging, endoscopy, biopsy, or specialist referral?
Could a prescription medicine, over-the-counter medicine, supplement, recent illness, or diet change alter the result?
Which trends should be monitored, and what interval is appropriate for my known condition?

Frequently Asked Questions About Digestive Health Lab Tests

Can blood tests diagnose digestive problems or gastrointestinal disorders?

Blood tests can identify patterns associated with digestive disease, including anemia, dehydration, systemic inflammation, nutrient deficiencies, celiac antibodies, infection-related changes, and abnormalities involving the liver, pancreas, or thyroid. However, blood tests usually cannot identify the exact location or cause of a digestive problem by themselves. Depending on the symptoms and results, stool testing, breath testing, imaging, endoscopy, colonoscopy, or biopsy may still be needed.

What blood tests are commonly used for digestive symptoms?

A CBC and CMP are common starting tests when anemia, infection-related changes, dehydration, electrolyte disturbance, low albumin, bilirubin, or liver-associated abnormalities are possible. CRP, ESR, iron studies, celiac serology, nutrient tests, or targeted thyroid testing may be added when the history supports them.

Can a blood test diagnose IBS?

No. There is no single blood test that confirms IBS. Clinicians identify a characteristic symptom pattern, look for warning signs, and use limited testing—such as celiac serology and, in selected diarrhea presentations, fecal calprotectin or other focused evaluation—to assess plausible alternatives.

What is the best first blood test for celiac disease?

For most people, tTG-IgA is the preferred initial antibody test, usually interpreted with Total IgA. IgG-based tests may be used when IgA deficiency is present or in selected specialist-directed contexts. Testing is most informative while eating gluten.

Why is Total IgA ordered with tTG-IgA?

Very low IgA can make an IgA-based celiac antibody test falsely negative. Total IgA helps show whether tTG-IgA and EMA-IgA are likely to be interpretable and whether an IgG-based strategy may be needed.

Can I stop eating gluten before a celiac test?

Do not begin a gluten-free diet before completing celiac testing without professional guidance. Antibodies and intestinal injury may decline after gluten removal, making blood tests and biopsy less conclusive. A person already gluten-free should discuss prior records, HLA Typing, or a supervised diagnostic plan rather than restarting gluten independently.

Does a positive celiac blood test mean I definitely have celiac disease?

It raises suspicion but does not complete every adult diagnosis. The antibody level, Total IgA, symptoms, gluten exposure, method, and related findings matter. Many adults need upper endoscopy with duodenal biopsies for confirmation.

What does fecal calprotectin test for?

Fecal Calprotectin measures a stool protein associated with intestinal neutrophilic inflammation. A higher result can occur with IBD, infection, medicine-related injury, and other conditions. It helps assess whether an inflammatory process is likely but does not identify the cause by itself.

Is FIT appropriate when I can already see blood in my stool?

No. FIT is principally a colorectal-screening test for eligible people without symptoms. Visible bleeding or black stool requires clinical evaluation to identify the source; a negative FIT should not delay that evaluation.

Which test checks for active H. pylori infection?

Stool Antigen and Urea Breath Testing are common noninvasive active-infection tests. Selected biopsy-based tests are used during endoscopy. Blood antibody testing cannot reliably distinguish current from past infection and is not appropriate for confirming eradication.

How soon after H. pylori treatment should I be retested?

Current ACG guidance recommends proof of eradication with an appropriately timed stool antigen, urea breath, or biopsy-based test at least four weeks after antibiotics. Acid-suppressing medicines can affect accuracy, so the medication and timing plan must follow professional and laboratory instructions.⁹

When is a stool pathogen panel useful?

It may be useful for severe, bloody, febrile, prolonged, travel-related, outbreak-associated, or immunocompromised diarrhea and when the result would change management or public-health action. It is not automatically necessary for every short, mild episode.

What is pancreatic elastase?

Pancreatic Elastase-1 is measured in stool and is a preferred initial test when exocrine pancreatic insufficiency is suspected. A solid or semisolid specimen is important because watery stool can dilute the marker and produce a falsely low result.

Do amylase and lipase diagnose chronic pancreatic insufficiency?

No. Blood Lipase and Amylase are primarily used during a compatible acute pancreatitis evaluation. Pancreatic elastase, selected fecal-fat testing, nutritional assessment, imaging, and specialist-directed pancreatic-function testing address different chronic questions.

Can thyroid problems cause digestive symptoms?

They can contribute to bowel-pattern changes. Hypothyroidism may be associated with constipation, while hyperthyroidism may be associated with frequent bowel movements, weight loss, heat intolerance, tremor, or palpitations. Targeted TSH and selected Free T4 may be appropriate when the history supports a thyroid question. These tests are not routine for every digestive complaint and do not replace evaluation for gastrointestinal warning signs.²⁷²⁸

Can normal digestive blood tests rule out serious disease?

No. Some inflammatory, structural, microscopic, pancreatic, gallbladder, and malignant disorders may have normal routine blood work. Persistent warning symptoms may still require stool testing, imaging, endoscopy, colonoscopy, biopsy, or specialist evaluation.

Are food-IgG or microbiome tests recommended for routine digestive symptoms?

They are not established replacements for validated celiac, allergy, IBD, infection, malabsorption, pancreatic, or structural evaluation. Proprietary scores may lack standardization and clear evidence that acting on the result improves outcomes.²⁴

Digestive Health Lab Tests: Main Takeaways

Digestive health testing may use blood, stool, breath, endoscopy, biopsy, imaging, or functional studies because each method answers a different question.
Blood tests can reveal anemia, dehydration, systemic inflammation, nutrient deficiency, celiac antibodies, liver-associated patterns, pancreatic enzyme elevation, and selected thyroid-related patterns, but they usually do not localize disease.
Celiac serology is most informative while gluten is being consumed; tTG-IgA with Total IgA is a common starting strategy for most people.
Fecal calprotectin and lactoferrin provide intestine-focused inflammatory information but do not diagnose the cause by themselves.
Active H. pylori is generally evaluated with stool antigen, urea breath, or selected biopsy-based testing, with careful attention to medicine and treatment timing.
Pancreatic elastase, fecal fat, blood lipase and amylase, and imaging answer different pancreatic and malabsorption questions.
Targeted TSH and Free T4 testing may add value when bowel-pattern changes occur with thyroid-compatible symptoms or history; it is not routine digestive screening.
Focused testing tied to a defined decision is generally more useful than an indiscriminate broad panel.
A normal result does not guarantee that serious disease is absent, and an abnormal result does not automatically establish a diagnosis.
Warning symptoms require professional or urgent evaluation and should not be delayed for direct-access laboratory testing.

Primary References

Your Digestive System & How It Works. National Institute of Diabetes and Digestive and Kidney Diseases.
Celiac Disease. American College of Gastroenterology.
Celiac Disease Tests. National Institute of Diabetes and Digestive and Kidney Diseases.
ACG Clinical Guideline: Management of Irritable Bowel Syndrome. American Journal of Gastroenterology. 2021.
AGA Clinical Practice Guidelines on the Laboratory Evaluation of Functional Diarrhea and Diarrhea-Predominant Irritable Bowel Syndrome in Adults. Gastroenterology. 2019.
American College of Gastroenterology Guidelines Update: Diagnosis and Management of Celiac Disease. American Journal of Gastroenterology. 2023.
Calprotectin Stool Test. MedlinePlus, U.S. National Library of Medicine.
The Role of Biomarkers for the Management of Ulcerative Colitis. American Gastroenterological Association.
ACG Guideline on Treatment of Helicobacter pylori: New Recommendations. American College of Gastroenterology. 2024.
Clinical Practice Guidelines for the Diagnosis and Management of Infectious Diarrhea. Infectious Diseases Society of America.
Clinical Testing and Diagnosis for C. difficile Infection. Centers for Disease Control and Prevention.
Diagnosis of Exocrine Pancreatic Insufficiency. National Institute of Diabetes and Digestive and Kidney Diseases.
AGA Clinical Practice Update on the Epidemiology, Evaluation, and Management of Exocrine Pancreatic Insufficiency. Gastroenterology. 2023.
Diagnosis of Lactose Intolerance. National Institute of Diabetes and Digestive and Kidney Diseases.
Colorectal Cancer: Screening. U.S. Preventive Services Task Force.
Diagnosis of GI Bleeding. National Institute of Diabetes and Digestive and Kidney Diseases.
Complete Blood Count. MedlinePlus.
Comprehensive Metabolic Panel. MedlinePlus.
C-Reactive Protein Test. MedlinePlus.
Erythrocyte Sedimentation Rate. MedlinePlus.
Ferritin Blood Test. MedlinePlus.
Vitamin B Test. MedlinePlus.
American College of Gastroenterology Guidelines: Management of Acute Pancreatitis. American Journal of Gastroenterology. 2024.
The Myth of IgG Food Panel Testing. American Academy of Allergy, Asthma & Immunology.
Diagnosis of Pancreatitis. National Institute of Diabetes and Digestive and Kidney Diseases.
Thyroid Tests. National Institute of Diabetes and Digestive and Kidney Diseases.
Hyperthyroidism. National Institute of Diabetes and Digestive and Kidney Diseases.
Diagnosis of Constipation. National Institute of Diabetes and Digestive and Kidney Diseases.

Editorial Disclosure, Authorship, and Medical Note

Ulta Lab Tests provides direct-access laboratory testing. Product links are included when they match the educational topic. Purchasing a test is not a substitute for diagnosis, treatment, imaging, endoscopy, biopsy, specialist care, or urgent medical evaluation.

Written by: John R. | Originally published: August 1, 2026 | Last updated: August 11, 2026

Medical note: This guide is educational. A clinician should select and interpret testing in the context of symptoms, diagnoses, medications, pregnancy status, nutrition, hydration, and prior results. Do not start, stop, or change a prescription based on this article or one laboratory result.

Tags: C. difficile testing, cbc test, celiac blood tests, celiac serology, CMP test, Crohn’s disease testing, CRP test, digestive disorder testing, Digestive health lab tests, ESR test, fecal calprotectin, fecal occult blood testing, FIT test, Folate deficiency, gallbladder tests, gastrointestinal bleeding, gastrointestinal blood tests, gastrointestinal pathogen panel, gluten-free diet before celiac testing, gut inflammation tests, H. pylori testing, IBS testing limitations, inflammatory bowel disease testing, iron deficiency anemia, lactose intolerance testing, malabsorption tests, nutrient deficiency testing, pancreatic elastase, pancreatic enzyme tests, pancreatitis testing, stool tests, total IgA, tTG-IgA, ulcerative colitis testing, Vitamin B12 deficiency

Recommended Lab Tests

1. Foundational Blood Tests

Complete Blood Count with Differential and Platelets,
Comprehensive Metabolic Panel,
C-Reactive Protein,
Sedimentation Rate,

2. Iron, Anemia, and Nutrient Tests

Ferritin,
Iron and Total Iron Binding Capacity,
Transferrin,
Reticulocyte Count,
Vitamin B12,
Folate, Serum,
Vitamin D, 25-Hydroxy, Total,
Magnesium,
Zinc,
Ferritin, Iron, and TIBC Panel,
Vitamin B12 and Folate Panel,

3. Celiac Disease Serology and Genetic Testing

Tissue Transglutaminase IgA Antibody,
Total IgA,
Endomysial IgA Antibody Screen with Reflex to Titer,
Deamidated Gliadin Peptide IgG and IgA Antibodies,
Tissue Transglutaminase IgG Antibody,
HLA Typing for Celiac Disease,
Celiac Disease Comprehensive Panel,
Celiac Disease – Comprehensive,

4. Stool Inflammation, Bleeding, and Screening Tests

Calprotectin Stool Test,
Lactoferrin, Qualitative, Stool,
FIT Test,
Fecal Globin by Immunochemistry,

5. H. pylori and Gastrointestinal Infection Tests

H. pylori Stool Antigen,
H. pylori Urea Breath Test,
Gastrointestinal Pathogen Panel,
Ova and Parasites Stool Examination,
Salmonella/Shigella Culture, Campylobacter EIA, and Shiga Toxin with Reflex,
C. difficile Toxin B,

6. Pancreatic and Fat-Malabsorption Tests

Pancreatic Elastase-1,
Fecal Fat, Qualitative,
Lipase,
Amylase,.

7. IBD Adjunctive and Differentiation Tests

Saccharomyces cerevisiae IgA Antibodies,
Saccharomyces cerevisiae IgG Antibodies,
ANCA Screen with Reflex to ANCA Titer,
Inflammatory Bowel Disease Differentiation Panel,

8. Liver, Gallbladder, and Bile-Flow Tests

Liver Function Panel,
Hepatic Function Panel with GGT,
Direct Bilirubin,

9. Focused Digestive Panels

Digestive Health – Basic,
Digestive Health – Advanced,
Inflammatory Bowel Disease – Basic,
Pancreatic Health Panel,
Gallbladder & Digestive Health Panel,
Nutrient Absorption & Deficiency Panel – Comprehensive,
Gut Health, Food Allergy & Nutrient Balance – Essential,
Gut Health, Food Allergy & Nutrient Balance – Advanced,
Gut Health, Food Allergy & Nutrient Balance – Comprehensive,